🇺🇸 FDA
Patent

US 9421241

Therapeutic modulation of ocular surface lubrication

granted A61KA61K31/568A61K31/685

Quick answer

US patent 9421241 (Therapeutic modulation of ocular surface lubrication) held by The Regents of the University of California expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/568, A61K31/685, A61K31/688, A61K31/715